Stockscreener 앱 받기
2.48
0.80%
-0.02
시간 외 거래:
2.50
0.02
+0.81%
전일 마감가:
$2.50
열려 있는:
$2.45
하루 거래량:
254.17K
Relative Volume:
2.12
시가총액:
$138.64M
수익:
-
순이익/손실:
$-21.38M
주가수익비율:
-6.359
EPS:
-0.39
순현금흐름:
$-25.19M
1주 성능:
+1.22%
1개월 성능:
-6.42%
6개월 성능:
+24.62%
1년 성능:
+184.18%
1일 변동 폭
$2.3701
$2.59
1주일 범위
$2.37
$2.59
52주 변동 폭
$0.51
$3.28
코넥트 바이오파마 Stock (CNTB) Company Profile
명칭
Connect Biopharma Holdings Ltd
전화
858-727-1040
주소
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.48 | 139.76M | 0 | -21.38M | -25.19M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.27 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.66 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.72 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.65 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.04 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
코넥트 바이오파마 Stock (CNTB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 개시 | Lake Street | Buy |
| 2025-10-31 | 개시 | BTIG Research | Buy |
| 2025-06-12 | 개시 | H.C. Wainwright | Buy |
| 2024-03-04 | 개시 | H.C. Wainwright | Buy |
| 2021-04-13 | 개시 | Jefferies | Buy |
| 2021-04-13 | 개시 | Piper Sandler | Overweight |
| 2021-04-13 | 개시 | SVB Leerink | Outperform |
모두보기
코넥트 바이오파마 주식(CNTB)의 최신 뉴스
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference - The Manila Times
CNTB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CNTB Technical Analysis & Stock Price Forecast - Intellectia AI
Connect Biopharma Touts Rademikibart as Fast-Acting Option for Acute Asthma, COPD Flare-Ups at Conference - MarketBeat
BML Capital Management LLC Sells 554,058 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat
KraneShares CSI China Internet ETF $KWEB Shares Purchased by Aurora Investment Managers LLC. - Defense World
Invesco QQQ $QQQ Stock Position Lessened by Concentrum Wealth Management - Defense World
JD.com, Inc. $JD Shares Acquired by Aurora Investment Managers LLC. - Defense World
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - The Manila Times
Watch Connect Biopharma's Oppenheimer health conference talk online - Stock Titan
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - Financial Times
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
CNTB PE Ratio & Valuation, Is CNTB Overvalued - Intellectia AI
What is HC Wainwright's Forecast for CNTB FY2028 Earnings? - MarketBeat
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Reno Gazette Journal
Equities Analysts Offer Predictions for CNTB FY2030 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
Analysts’ Top Healthcare Picks: Context Therapeutics (CNTX), Connect Biopharma Holdings (CNTB) - The Globe and Mail
3 Promising Penny Stocks With Market Caps Up To $400M - Yahoo Finance
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
OPAL Fuels Inc. (NASDAQ:OPAL) Given Average Recommendation of “Reduce” by Analysts - Defense World
NVR, Inc. (NYSE:NVR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Contrasting Joint Stock Company Kaspi.kz (NASDAQ:KSPI) & PagSeguro Digital (NYSE:PAGS) - Defense World
Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7%What's Next? - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7% – What’s Next? - Defense World
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026 - The Manila Times
Connect Biopharma Reports Significant Loss Amid Development Efforts - MSN
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - news-journalonline.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma Announces Board Resignation - TradingView — Track All Markets
Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks - simplywall.st
Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Connect Biopharma Hldgs (CNTB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22% - Yahoo Finance
Analyzing Connect Biopharma (NASDAQ:CNTB) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives $8.50 Average Price Target from Analysts - Defense World
Connect Biopharma (NASDAQ:CNTB) Now Covered by Analysts at Lake Street Capital - MarketBeat
Check Out Connect Biopharma Holdings Ltd (CNTB)’s Trade Data Rather Than the Analysts’ Views - Setenews
Connect Biopharma (NASDAQ:CNTB) Research Coverage Started at Lake Street Capital - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Lake Street Initiates Coverage on Connect Biopharma (CNTB) with 'Buy' Rating | CNTB Stock News - GuruFocus
코넥트 바이오파마 (CNTB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.71%
0.02%
자본화:
|
볼륨(24시간):